Atlas Trials

Recurrent Childhood Malignant Germ Cell Tumor

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Childhood Malignant Germ Cell Tumor

RecordFirmDate
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) (NCT03210714)National Cancer Institute (NCI)2018-06-05
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) (NCT03233204)National Cancer Institute (NCI)2017-09-14
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500)National Cancer Institute (NCI)2009-08-01
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors (NCT00467051)Children's Oncology Group2007-11-05
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898)City of Hope Medical Center2007-02-26
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270)National Cancer Institute (NCI)2005-03-01
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182)National Cancer Institute (NCI)2004-10-01
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors (NCT00077454)National Cancer Institute (NCI)2004-02-01
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas (NCT00012181)National Cancer Institute (NCI)2001-04-01

Track Recurrent Childhood Malignant Germ Cell Tumor automatically

Every clearance here is in the API, with alerts when new ones post.